Managing Director, FasterCures
Kim McCleary leads a new FasterCures program to advance the science of patient input and expand patient engagement in the Food and Drug Administration's (FDA) assessment of benefits and risks for medical products. McCleary also works closely with FasterCures' network of patient-focused venture philanthropy organizations, The Research Acceleration and Innovation Network (TRAIN). Prior to joining FasterCures, McCleary was president & CEO of the CFIDS Association of America from 1991 until 2013. She has participated in every opportunity organized by the FDA to shape its Patient-Focused Drug Development Initiative. McCleary is a member of the Patient Engagement Advisory Panel to the Patient-Centered Outcomes Research Institute and serves on the steering committee for the Medical Device Innovation Consortium's Patient-Centered Benefit Risk project.